These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36543134)

  • 1. MED13 and glycolysis are conserved modifiers of α-synuclein-associated neurodegeneration.
    Ren M; Yang Y; Heng KHY; Ng LY; Chong CY; Ng YT; Gorur-Shandilya S; Lee RMQ; Lim KL; Zhang J; Koh TW
    Cell Rep; 2022 Dec; 41(12):111852. PubMed ID: 36543134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity.
    Olsen AL; Feany MB
    Neurobiol Dis; 2021 Nov; 159():105482. PubMed ID: 34390834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
    Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
    J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Druggable Genome Screen Identifies Modifiers of α-Synuclein Levels via a Tiered Cross-Species Validation Approach.
    Rousseaux MWC; Vázquez-Vélez GE; Al-Ramahi I; Jeong HH; Bajić A; Revelli JP; Ye H; Phan ET; Deger JM; Perez AM; Kim JY; Lavery LA; Xu Q; Li MZ; Kang H; Kim JJ; Shulman JM; Westbrook TF; Elledge SJ; Liu Z; Botas J; Zoghbi HY
    J Neurosci; 2018 Oct; 38(43):9286-9301. PubMed ID: 30249792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.
    Knight AL; Yan X; Hamamichi S; Ajjuri RR; Mazzulli JR; Zhang MW; Daigle JG; Zhang S; Borom AR; Roberts LR; Lee SK; DeLeon SM; Viollet-Djelassi C; Krainc D; O'Donnell JM; Caldwell KA; Caldwell GA
    Cell Metab; 2014 Jul; 20(1):145-57. PubMed ID: 24882066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the Cover: Arsenic Induces Accumulation of α-Synuclein: Implications for Synucleinopathies and Neurodegeneration.
    Cholanians AB; Phan AV; Ditzel EJ; Camenisch TD; Lau SS; Monks TJ
    Toxicol Sci; 2016 Oct; 153(2):271-81. PubMed ID: 27413109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.
    Roy B; Jackson GR
    Hum Mol Genet; 2014 Jun; 23(11):3008-23. PubMed ID: 24430504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson's disease.
    Jakova E; Moutaoufik MT; Lee JS; Babu M; Cayabyab FS
    Transl Neurodegener; 2022 Feb; 11(1):9. PubMed ID: 35139916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease-associated
    Mori A; Hatano T; Inoshita T; Shiba-Fukushima K; Koinuma T; Meng H; Kubo SI; Spratt S; Cui C; Yamashita C; Miki Y; Yamamoto K; Hirabayashi T; Murakami M; Takahashi Y; Shindou H; Nonaka T; Hasegawa M; Okuzumi A; Imai Y; Hattori N
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20689-20699. PubMed ID: 31548400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein arginylation in the human brain.
    Zhao J; Pan B; Fina M; Huang Y; Shimogawa M; Luk KC; Rhoades E; Petersson EJ; Dong DW; Kashina A
    Transl Neurodegener; 2022 Apr; 11(1):20. PubMed ID: 35395956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal attraction - The role of hypoxia when alpha-synuclein gets intimate with mitochondria.
    Burtscher J; Syed MMK; Keller MA; Lashuel HA; Millet GP
    Neurobiol Aging; 2021 Nov; 107():128-141. PubMed ID: 34428721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential mitochondrial roles for α-synuclein in DRP1-dependent fission and PINK1/Parkin-mediated oxidation.
    Krzystek TJ; Banerjee R; Thurston L; Huang J; Swinter K; Rahman SN; Falzone TL; Gunawardena S
    Cell Death Dis; 2021 Aug; 12(9):796. PubMed ID: 34404758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine Particulate Matter Triggers α-Synuclein Fibrillization and Parkinson-like Neurodegeneration.
    Yuan X; Yang Y; Liu C; Tian Y; Xia D; Liu Z; Pan L; Xiong M; Xiong J; Meng L; Zhang Z; Ye K; Jiang H; Zhang Z
    Mov Disord; 2022 Sep; 37(9):1817-1830. PubMed ID: 36054165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.
    Serratos IN; Hernández-Pérez E; Campos C; Aschner M; Santamaría A
    Mol Neurobiol; 2022 Jan; 59(1):620-642. PubMed ID: 34750787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson's disease in Drosophila.
    Liu W; Lim KL; Tan EK
    Transl Neurodegener; 2022 Oct; 11(1):44. PubMed ID: 36253844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of Glucocerebrosidase Gene in
    Abul Khair SB; Dhanushkodi NR; Ardah MT; Chen W; Yang Y; Haque ME
    Front Neurosci; 2018; 12():81. PubMed ID: 29503608
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.
    Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT
    Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.